Debt Restructuring

The nation's largest portable sanitation provider moves its HQ to Meridian, ID, just after a $2.4B debt reduction, signaling a major strategic shift.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

The midstream firm is refinancing debt and buying back preferred units, aiming for a simpler, more flexible financial future. What does this mean for NGL?

Lucara Diamond Corp. finalizes a massive financing package for its Karowe mine expansion, averting a crisis but taking on costly debt to secure its future.

The European FinTech strengthens its balance sheet with a perpetual bond issuance, signaling strong investor confidence and fueling its expansion plans.

Kodiak AI now has 20 driverless trucks on the road, an industry first. But with mounting losses, can its tech innovation outpace its high cash burn?

A $125M loan for the first building in the Gowanus Wharf campus signals huge confidence in Brooklyn's transformation, blending luxury living with affordable housing.

AEON Biopharma hires a seasoned CFO to navigate FDA trials and financial hurdles as it aims to launch its BOTOX biosimilar into a lucrative market.

With its runway extended by insiders, the biotech firm bets on its promising glioblastoma drug and an unconventional strategy of crypto and acquisitions.

Allarity Therapeutics lands a crucial $20M debt deal to push its unique ovarian cancer drug, stenoparib, through late-stage trials and extend its runway to 2028.

As Thames Water faces collapse, a new investigative podcast brings together key experts to dissect the systemic failures behind England's polluted rivers.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

Applied Digital seeks massive debt to build a new AI factory, a high-stakes gamble in the race to power the future of artificial intelligence.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

With over 90% investor participation, Gran Tierra Energy extends its debt maturity to 2031, securing crucial financial flexibility in a volatile market.

Hawaiian Electric Industries reports a dramatic financial turnaround, but the utility's path forward is defined by massive investments in grid safety and renewables.

Aragon Research names LivePerson a Leader as the market shifts from chatbots to sophisticated AI agents, highlighting its focus on trust and reliability.

Caliber sells a Phoenix-area hotel to recycle capital into its Hospitality Trust, eyeing distressed assets in a bold 2026-2027 growth strategy.

MedX Health Corp. lands a crucial $2.7M in initial funding, aiming for $5M to expand its skin-screening tech into occupational health and manage debt.